search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
NEWS Aptar


buys Gulf Closures


Aptar Closures is adding manufacturing capabilities in the Middle East with the acquisition of a majority stake in Gulf Closures, which makes beverage closure products in Bahrain. The acquisition will


allow Aptar Closures to leverage its global business capabilities together with Gulf Closures’ manufacturing expertise, regional network, and experienced team to better serve the company’s existing customers in the Middle East while opening new market opportunities and strengthening its pres- ence in the region. Gulf Closures currently employs approximately 60 people at its facility in Bahrain. It is a partner to several global and other major local beverage brands in Gulf Coopera- tion Council (GCC) countries, Levant, and Africa. Since January 2023, Aptar has realigned its segments to provide a specific focus on closures through the segment Aptar Closures. �www.aptar.com


Envalior: new name in engineering plastics


Envalior is the name that has been chosen for the com- bined Lanxess High Perfor- mance Materials and DSM Engineering Materials businesses under the ownership of Advent International and Lanxess. The new joint venture company, which was announced last year, says it will offer a unique portfolio of established product brands combined with deep applica- tion and materials expertise. With a turnover of around €4bn and a workforce of around 4,000 worldwide, Envalior ranks among the top engineering materials companies globally with a strong footprint in Asia, Europe, and the US. The


Calum MacLean, CEO of the joint venture between Advent International and Lanxess


company’s high-perfor- mance materials are supplied to industries including automotive and new mobility, electronics and electrical. Calum MacLean, CEO of Envalior, said: “Our new


company’s product portfolio includes some of the most recognisable product brands in our industry. By combining two highly complementary businesses, we have created a true industry leader that will realise value and drive progress for our customers, employees, shareholders, and society as a whole.” Matthias Zachert, CEO of


Lanxess, added: “With the joint venture, we are launching a global cham- pion in high-performance polymers. The company has all it takes to actively shape future trends such as in new mobility and to benefit from its great growth potential.” � https://envalior.com


Utz commissions KM giant


KraussMaffei says Switzer- land’s Georg Utz has commissioned the country’s largest injection moulding machine, an MX 4000- 75000 with a clamping force of 40,000 kN. The machine was


transported on 22 trucks from Munich to Bremgarten, and after 12 weeks of set-up, the MX 4000 went


online on the requested target date, replacing an older, less efficient machine. The upgraded model


features a sophisticated two- storey automation system that implements subsequent process steps such as the application of RFIDs, IML barcodes and logos, plus post-processing and quality assurance within the cycle


time. The two KraussMaffei LRX robots have 12m-long Z-axes providing a particu- larly large working radius. Utz runs three shifts at its plant on the new MX 4000, producing approximately 20 different products with weights of up to 50 kg, including pallets and boxes. �www.kraussmaffei.com �www.utzgroup.ch


Norwood Medical expands at its HQ in Ohio


Norwood Medical has begun construc- tion of the eleventh building at its HQ in Dayton, Ohio. The construction of the 22,000 m² building will be a significant addition to Norwood’s current 198,000 m² footprint and will


6 INJECTION WORLD | April 2023


enable the company to design a state-of-the art manufacturing facility, which will focus on producing compo- nents for minimally invasive and robotic-assisted surgeries. The new building, when commis-


sioned and operational in 2024, will enable Norwood to increase its capabilities in laser-induced processes, automation and AI. Its strategic goal is to produce 35m parts per year. �www.norwoodmedical.com


www.injectionworld.com


IMAGE: ENVALIOR


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54